DEF 14AThe Ballot
RECURSION PHARMACEUTICALS, INC. files DEF 14A
Filed Apr 28, 2022 · 4y ago · Accession 0001601830-22-000017
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Ticker
- RXRX
- CIK
- 1601830
- Form type
- DEF 14A
- Filing date
- Apr 28, 2022
- Report date
- Jun 14, 2022
- Document
- rxrx_proxystatement2022.htm
- Size
- 15.5 MB